Cite
Sewaralthahab K, Rennke H, Sewaralthahab S, et al. Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis. Clin Nephrol Case Stud. 2014;3:31-36doi: 10.5414/CNCS108420.
Sewaralthahab, K., Rennke, H., Sewaralthahab, S., Madias, N. E., & Jaber, B. L. (2015). Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis. Clinical nephrology. Case studies, 331-36. https://doi.org/10.5414/CNCS108420
Sewaralthahab, Kamal, et al. "Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis." Clinical nephrology. Case studies vol. 3 (2015): 31-36. doi: https://doi.org/10.5414/CNCS108420
Sewaralthahab K, Rennke H, Sewaralthahab S, Madias NE, Jaber BL. Potential association between membranous nephropathy and sargramostim therapy for pulmonary alveolar proteinosis. Clin Nephrol Case Stud. 2014 Dec 15;3:31-36. doi: 10.5414/CNCS108420. eCollection 2015. PMID: 29043131; PMCID: PMC5437997.
Copy
Download .nbib